Asthma drug found to rejuvenate older rat brains

October 28, 2015 by Bob Yirka, Medical Xpress report

Cerebellum of CIVM postnatal rat brain atlas. Credit: Neurolex
(Medical Xpress)—A European team of researchers working in Austria has found that a drug commonly prescribed to treat asthma can lead to rejuvenation in an older rat brain. In their paper published in the journal Nature Communications, the group describes their study that involved giving the drug to rats and then testing them on their cognitive and memory abilities.

As people grow older, cognitive abilities diminish, along with a decline in memory skills—that that has driven scientists to study aging and the brain and has led to the discovery that most of the decline is due to inflammation in the brain, which comes about when certain receptors are activated. In this new effort, the researchers looked at the drug montelukast because it lessens the problems associated with asthma by reducing inflammation in the lungs. They thought it might do the same for the brain.

To find out, they gave a small group of 20 month-old (analogous to 65 years in humans) test rats the drug for six weeks and then compared their against 4 month-old rats, by testing both groups to see how well they were able to learn a new task—in this case, to look for an underwater platform. The older rats were selected as average representatives—they did not suffer from a neurodegenerative disease, just the loss of abilities as part of the normal aging process. In studying the results, the researchers found that the older rats were nearly as able to learn the new task as the younger mice, unlike other untreated rats of the same age.

When they tested the same rats two weeks later, they found that the treated rats were just as capable of remembering what they had learned as the younger rats, again, unlike untreated rats.

The team then dissected the brains of the treated rats and found new neural growth, which was uncharacteristic of rats their age—there was also less inflammation. The team also found that the blood-brain barrier had less seepage than rats normally would at their age, another indicator of a reduction in inflammation.

In a separate study, the team also studied mouse cells that had been genetically modified to generate less of the receptors that have been identified as causing in the brain, and found that the results were very similar to the that had been given montelukast, suggesting the worked in similar ways.

While the results by the researchers are promising, it is still not clear if the same results could be found in humans—that will have to await the results of clinical trials.

Explore further: Extremely active rats become lazy when they artificially receive 'runners' high'

More information: Julia Marschallinger et al. Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug, Nature Communications (2015). DOI: 10.1038/ncomms9466

Abstract
As human life expectancy has improved rapidly in industrialized societies, age-related cognitive impairment presents an increasing challenge. Targeting histopathological processes that correlate with age-related cognitive declines, such as neuroinflammation, low levels of neurogenesis, disrupted blood–brain barrier and altered neuronal activity, might lead to structural and functional rejuvenation of the aged brain. Here we show that a 6-week treatment of young (4 months) and old (20 months) rats with montelukast, a marketed anti-asthmatic drug antagonizing leukotriene receptors, reduces neuroinflammation, elevates hippocampal neurogenesis and improves learning and memory in old animals. By using gene knockdown and knockout approaches, we demonstrate that the effect is mediated through inhibition of the GPR17 receptor. This work illustrates that inhibition of leukotriene receptor signalling might represent a safe and druggable target to restore cognitive functions in old individuals and paves the way for future clinical translation of leukotriene receptor inhibition for the treatment of dementias.

Related Stories

Extremely active rats become lazy when they artificially receive 'runners' high'

October 6, 2015
Past research has shown that the pleasure and reward centers of the brain are activated similarly by dangerous drugs as well as by exercise, which is why therapies have been developed for drug addicts that include lots of ...

Rats found able to recognize pain in other rat faces

April 1, 2015
(Phys.org)—A team of researchers working in Japan with affiliations to several institutions in that country, has found that lab rats are able to recognize pain in the faces of other rats and avoid them when given the opportunity. ...

Researchers find drug therapy that could eventually reverse memory decline in seniors

March 5, 2014
It may seem normal: As we age, we misplace car keys, or can't remember a name we just learned or a meal we just ordered. But University of Florida researchers say memory trouble doesn't have to be inevitable, and they've ...

Female rats struggle to find their way in BPA study

October 20, 2015
Despite concerns about bisphenol A (BPA), academic and regulatory scientists have yet to reach a consensus on BPA's safety.

Neurons in rat brains responsible for monitoring speed identified

July 16, 2015
(Medical Xpress)—A team of researchers working at the Norwegian University of Science and Technology has isolated the neurons in the rat brain that are responsible for monitoring speed as rats run, walk or stop moving around. ...

Compound found in grapes, red wine may help prevent memory loss

February 4, 2015
A compound found in common foods such as red grapes and peanuts may help prevent age-related decline in memory, according to new research published by a faculty member in the Texas A&M Health Science Center College of Medicine.

Recommended for you

Team's study reveals hidden lives of medical biomarkers

October 12, 2018
What do medical biomarkers do on evenings and weekends, when they might be considered off the clock?

Widespread errors in 'proofreading' cause inherited blindness

October 12, 2018
Mistakes in "proofreading" the genetic code of retinal cells is the cause of a form of inherited blindness, retinitis pigmentosa (RP) caused by mutations in splicing factors.

Researchers create a functional salivary gland organoid

October 11, 2018
A research group led by scientists from Showa University and the RIKEN Center for Biosystems Dynamics Research in Japan have, for the first time, succeeded in growing three-dimensional salivary gland tissue that, when implanted ...

Lassa fever vaccine shows promise and reveals new test for immunity

October 11, 2018
Lassa fever belongs to the same class of hemorrhagic fevers as Ebola. Like Ebola, it has been a major health threat in Western Africa, infecting 100,000-300,000 people and killing 5,000 per year. A new vaccine against both ...

Genetically engineered 3-D human muscle transplant in a murine model

October 10, 2018
A growing need for tissues and organs in surgical reconstruction is addressed by the promising field of tissue engineering. For instance, muscle atrophy results from severe traumatic events including deep burns and cancer, ...

Engineers develop process to 3-D print cells to produce human tissue such as ligaments and tendons

October 10, 2018
With today's technology, we can 3-D-print sculptures, mechanical parts, prosthetics, even guns and food. But a team of University of Utah biomedical engineers have developed a method to 3-D-print cells to produce human tissue ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.